Although only association and not causality can be inferred, this study showed that, among patients who had diabetes, an elevated risk of NAION was associated with semaglutide use compared with ...

Lack of pain Ischemic optic neuropathy, NMO-associated optic ... and often occurrs as the heralding event of the disease. Optical coherence tomography has revolutionized the evaluation of vision ...

The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those taking drugs for ...

The higher risk of developing the sight-threatening eye problem known as nonarteritic anterior ischemic optic neuropathy, or NAION, did not appear during patients’ first year of treatment with ...

More information: Alan Y. Hsu et al, Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes, JAMA Ophthalmology (2025). DOI: 10.1001/jamaophthalmol.2025.0349 ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.